Athira Pharmainc Stock In The News
| ATHA Stock | USD 2.71 0.50 22.62% |
The tone or emotional content of news articles related to Athira PharmaInc can affect its prices. Positive news sentiment can lead to an increase in demand for Athira PharmaInc's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Athira PharmaInc's news coverage and content from conventional and social sources shows investors' bearish mood towards Athira PharmaInc. The specific impact of Athira PharmaInc news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Athira PharmaInc's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Athira PharmaInc headlines in addition to utilizing other, more conventional financial analysis modules. Check out Athira PharmaInc Backtesting and Athira PharmaInc Hype Analysis. For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.
Athira |
Athira PharmaInc Today Top News and Investor Outlook
Athira PharmaInc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Athira and other traded companies coverage. We help investors stay connected with Athira headlines for the 17th of May 2024 to make an informed investment decision based on correlating the impacts of news items on Athira Stock performance. Please note that trading solely based on the Athira PharmaInc hype is not for everyone as timely availability and quick action are needed to avoid losses.Athira PharmaInc stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Athira earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Athira PharmaInc that are available to investors today. That information is available publicly through Athira media outlets and privately through word of mouth or via Athira internal channels. However, regardless of the origin, that massive amount of Athira data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Athira PharmaInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Athira PharmaInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Athira PharmaInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Athira PharmaInc alpha.
Athira Largest EPS Surprises
Earnings surprises can significantly impact Athira PharmaInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-08-16 | 2021-06-30 | -0.34 | -0.38 | -0.04 | 11 | ||
2021-05-13 | 2021-03-31 | -0.3 | -0.25 | 0.05 | 16 | ||
2021-11-10 | 2021-09-30 | -0.5 | -0.42 | 0.08 | 16 | ||
2022-03-24 | 2021-12-31 | -0.54 | -0.45 | 0.09 | 16 | ||
2024-05-15 | 2024-03-31 | -0.79 | -0.69 | 0.1 | 12 | ||
2022-11-10 | 2022-09-30 | -0.63 | -0.53 | 0.1 | 15 |
Athira PharmaInc Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Athira PharmaInc Stock. The global stock market is bullish. About 66% of major world exchanges and indexes are currently up. See today's market update for more information.
26th of April 2024
Atha Energy announces company has entered into option agreement with Inspiration Energy at finance.yahoo.com
16th of April 2024
Athira Pharmas US14m Market Cap Fall Books Insider Losses at simplywall.st
15th of April 2024
Athira Pharma appoints new Chief Medical Officer at investing.com
11th of April 2024
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatmen... at globenewswire.com
4th of April 2024
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors - ... at news.google.com
3rd of April 2024
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology 2024... at finance.yahoo.com
27th of March 2024
ATHA Energy Announces 92 Energy Obtains Court Approval at finance.yahoo.com
15th of March 2024
Athira Pharma, Inc. Short Interest Update - MarketBeat at news.google.com
8th of March 2024
Athira reports pro-cognitive effects of fosgonimeton at investing.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Athira PharmaInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Athira PharmaInc's short interest history, or implied volatility extrapolated from Athira PharmaInc options trading.
Check out Athira PharmaInc Backtesting and Athira PharmaInc Hype Analysis. For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.Note that the Athira PharmaInc information on this page should be used as a complementary analysis to other Athira PharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Athira Stock analysis
When running Athira PharmaInc's price analysis, check to measure Athira PharmaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athira PharmaInc is operating at the current time. Most of Athira PharmaInc's value examination focuses on studying past and present price action to predict the probability of Athira PharmaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athira PharmaInc's price. Additionally, you may evaluate how the addition of Athira PharmaInc to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Athira PharmaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Athira PharmaInc. If investors know Athira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Athira PharmaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Return On Assets (0.38) | Return On Equity (0.64) |
The market value of Athira PharmaInc is measured differently than its book value, which is the value of Athira that is recorded on the company's balance sheet. Investors also form their own opinion of Athira PharmaInc's value that differs from its market value or its book value, called intrinsic value, which is Athira PharmaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Athira PharmaInc's market value can be influenced by many factors that don't directly affect Athira PharmaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Athira PharmaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Athira PharmaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Athira PharmaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.